Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA.

PloS One
Shanta ZimmerTed Ross

Abstract

In April 2009, a new pandemic strain of influenza infected thousands of persons in Mexico and the United States and spread rapidly worldwide. During the ensuing summer months, cases ebbed in the Northern Hemisphere while the Southern Hemisphere experienced a typical influenza season dominated by the novel strain. In the fall, a second wave of pandemic H1N1 swept through the United States, peaking in most parts of the country by mid October and returning to baseline levels by early December. The objective was to determine the seroprevalence of antibodies against the pandemic 2009 H1N1 influenza strain by decade of birth among Pittsburgh-area residents. Anonymous blood samples were obtained from clinical laboratories and categorized by decade of birth from 1920-2009. Using hemagglutination-inhibition assays, approximately 100 samples per decade (n = 846) were tested from blood samples drawn on hospital and clinic patients in mid-November and early December 2009. Age specific seroprevalences against pandemic H1N1 (A/California/7/2009) were measured and compared to seroprevalences against H1N1 strains that had previously circulated in the population in 2007, 1957, and 1918. (A/Brisbane/59/2007, A/Denver/1/1957, and A/South Carolina...Continue Reading

References

Oct 1, 1976·Hospital Practice·A D Langmuir, S C Schoenbaum
Sep 30, 1976·The New England Journal of Medicine·S C SchoenbaumJ Kavet
Jul 4, 1998·The Journal of Infectious Diseases·L SimonsenK Fukuda
May 4, 2001·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·C B BridgesUNKNOWN Advisory Committee on Immunization Practices
Sep 1, 1955·Annals of Internal Medicine·T FRANCIS
Aug 1, 1956·The Journal of Experimental Medicine·K E JENSENT FRANCIS
Feb 24, 2006·Emerging Infectious Diseases·Edwin D Kilbourne
Feb 28, 2006·The American Journal of Forensic Medicine and Pathology·Bl Meel
Aug 28, 2007·Vaccine·F Carrat, A Flahault
Oct 19, 2007·Journal of Virology·Yiming BaoDavid Lipman
Mar 28, 2008·PLoS Medicine·Joël MossongW John Edmunds
Apr 22, 2008·Nucleic Acids Research·A DereeperO Gascuel
May 9, 2009·The New England Journal of Medicine·Fatimah S DawoodTimothy M Uyeki
May 9, 2009·The New England Journal of Medicine·Vivek ShindeLyn Finelli
May 13, 2009·Science·Christophe FraserUNKNOWN WHO Rapid Pandemic Assessment Collaboration
Aug 4, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jin Hyang KimJoshy Jacob
Sep 12, 2009·The New England Journal of Medicine·Kathy HancockJacqueline M Katz
Oct 22, 2009·AAOHN Journal : Official Journal of the American Association of Occupational Health Nurses·Sheila M Litchfield
Nov 27, 2009·The New England Journal of Medicine·James F BishopRhonda Owen
Dec 8, 2009·Emerging Infectious Diseases·Carrie ReedLyn Finelli
Aug 8, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jin Hyang KimJoshy Jacob

❮ Previous
Next ❯

Citations

Oct 20, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Danuta M SkowronskiMartin Petric
Oct 27, 2010·PloS One·Don BandaranayakeUNKNOWN 2009 H1N1 Serosurvey Investigation Team
Mar 24, 2011·American Journal of Epidemiology·Dennis L ChaoIra M Longini
Sep 6, 2011·Emerging Infectious Diseases·Sandra JohnsonEamonn O'Moore
Sep 13, 2011·PloS One·Chih-Jung ChenTzou-Yien Lin
Oct 12, 2013·PloS One·Stefano MerlerCaterina Rizzo
Nov 28, 2012·The Journal of Infectious Diseases·Arnaud OrelleJean-Michel Heraud
Nov 9, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C ReinheimerR Allwinn
Mar 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eric J KasowskiCarolyn B Bridges
Nov 18, 2010·Expert Review of Molecular Diagnostics·Edward N BrodyDom Zichi
Jun 1, 2012·Expert Opinion on Drug Discovery·Qi-Shi DuKuo-Chen Chou
Jan 3, 2012·Theoretical Population Biology·Adam J Kucharski, Julia R Gog
Jul 27, 2011·Vaccine·Kåre MølbakSteffen Glismann
Jan 22, 2013·Influenza and Other Respiratory Viruses·Maria D Van KerkhoveUNKNOWN H1N1pdm serology working group
Feb 15, 2012·Influenza and Other Respiratory Viruses·Alexanderyn BurmaaPagbajabyn Nymadawa
Mar 16, 2012·Influenza and Other Respiratory Viruses·Dat TranLillian Sung
Nov 24, 2011·PloS One·Camille AchonuNatasha S Crowcroft
Jul 10, 2012·Journal of the Royal Society, Interface·E GoldsteinM Lipsitch
Feb 15, 2017·The American Journal of Pathology·Derek A PociaskJohn F Alcorn

❮ Previous
Next ❯

Methods Mentioned

BETA
protein assay

Software Mentioned

Gblocks
PhyML
MUSCLE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.